ARKA Clinical Decision Support is designed to meet all four criteria for Non-Device CDS under FD&C Act §520(o)(1)(E) and FDA's January 2026 final guidance on Clinical Decision Support Software. Recommendations support, not replace, the clinician's judgment. Every recommendation is anchored in a published guideline or peer-reviewed source, with the basis available for independent review. CLIN emphasizes imaging appropriateness at order entry.
This recommendation is intended to support, not replace, clinical judgment. It is generated by ARKA, software designed to meet the four criteria for Non-Device Clinical Decision Support under FD&C Act §520(o)(1)(E) and FDA's final guidance on Clinical Decision Support Software (January 2026). The clinician is responsible for the final decision.
AIIE Evidence
Order TTE for every new heart failure diagnosis — EF classification (HFrEF/HFmrEF/HFpEF) determines the entire treatment algorithm.
Transthoracic echocardiography is the cornerstone initial imaging study for newly suspected heart failure, establishing ejection fraction, chamber size, and valvular function that classify the syndrome and direct guideline-based therapy.
The AIIE synthesis above is ARKA-authored; the sources below are the underlying external literature.
Circulation · 2022doi:10.1161/CIR.0000000000001063
American College of Radiology · 2024